Opinion · 1 Dec 2025
Conference abstractPublished 26 Feb 2018
Relaxing the tension between publishing and patenting
A A Thornton Ã?¢Ã?Â?Ã?Â? Intellectual Property Law, UK
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Timing is everything. This is true not only in the world of scientific research, but also in the world of patents. It is especially so in the pharmaceutical field. There is often a tension between, on one hand Ã?¢Ã?Â?Ã?Â? the desire to publish new scientific research or developments and on the other Ã?¢Ã?Â?Ã?Â? the commercial need for valid patents on certain aspects or applications of that R&D. However, this does not need to be the case. This presentation will briefly outline the legal basis behind why it is always important to consider when and what is made public prior to filing a patent application and even afterwards. The global village in which the pharmaceutical industry is situated will be considered with international legal aspects, including not only those in the US and Europe but also those of South America, Asia and the Far East. These matters will be illustrated by some famous examples, including those of penicillin and monoclonal antibodies. The presentation will then turn its focus to providing practical, legally sound and commercially savvy advice on how to reduce the risk to any patent applications based on such R&D. Account will be taken not only of timing but also of how: the prior art is summarised; the new R&D described; and conclusions or proposals for future work addressed.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Pharmacoeconomics: Open Access.
Short communication · 1 Dec 2025
Preventive Drugs for Older Adults: Health and Economic Benefits
Brief report · 29 Nov 2025
Value Assessment Of High-cost Specialty Drugs
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmacoeconomics: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Julie Barrett Major”
- BylineArticles whose byline prints “Lucy O Brien”

